Continuing Education Information

Continuing Education Credits

The Society for Immunotherapy of Cancer (SITC) is pleased to offer opportunities for physicians, nurses and pharmacists to obtain Continuing Education credits for their participation in the 32nd Annual Meeting, Workshop and Primer.

Jointly provided by the Postgraduate Institute for Medicine and the Society for Immunotherapy of Cancer.

PIM.jpg sitc_log_color.png

Physician Continuing Medical Education

Accreditation Statement

The 32nd Annual Meeting, Workshop and Primer have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and the Society for Immunotherapy of Cancer. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

These activities have been approved for AMA PRA Category 1 Credit(s)TMAnnual Meeting, Workshop, and Primer, for a maximum of 20.75 AMA PRA Category 1 Credit(s)™, 7.5 AMA PRA Category 1 Credit(s)™, and 7.5 AMA PRA Category 1 Credit(s)™, respectively. Physicians should claim only the credit commensurate with the extent of their participation in the activities.

A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be emailed to you within 3-4 weeks.

Pharmacist Continuing Education

Accreditation Statement

apce.pngPostgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 

Credit Designation

Annual Meeting, Workshop and Primer, for up to 21 (2.1 CEUs), 7.4 (0.74 CEUs), and 7.75 (0.775 CEUs) contact hours of the Accreditation Council for Pharmacy Education, respectively.

32nd Annual Meeting: Postgraduate Institute for Medicine designates this continuing education activity for 21 contact hour(s) (2.1 CEUs) of the Accreditation Council for Pharmacy Education

  • UAN: 0809-9999-17-638-L01-P; Knowledge (Update Session & Keynote Address; 1.5 hours)
  • UAN: 0809-9999-17-639-L01-P; Knowledge (Science Behind the Therapy: Mechanisms of Efficacy & Toxicity; 2.5 hours)
  • UAN: 0809-9999-17-661-L01-P; Knowledge (Late Breaking Abstract Session I; 0.5 hours)
  • UAN: 0809-9999-17-640-L01-P; Knowledge (Building Personalized Vaccines and Technologies for Hematologic Malignancies and Solid Tumors; 1.5 hours)
  • UAN: 0809-9999-17-641-L01-P; Knowledge (High Impact Clinical Trial Results; 1.5 hours)
  • UAN: 0809-9999-17-642-L01-P; Knowledge (CS1: Oncolytic Viruses and Intratumoral Therapies; 1.5 hours)
  • UAN: 0809-9999-17-643-L01-P; Knowledge (CS2: Energizing Immune Cell Metabolism in Cancer; 1.5 hours)
  • UAN: 0809-9999-17-644-L01-P; Knowledge (Update Session & Smalley Keynote; 1.5 hours)
  • UAN: 0809-9999-17-645-L01-P; Knowledge (Mechanisms of Acquired Resistance to Immunotherapies; 2.25 hours)
  • UAN: 0809-9999-17-646-L01-P; Knowledge (Late-Breaking Abstract Session II; 0.5 hours)
  • UAN: 0809-9999-17-647-L01-P; Knowledge (Presidential Session; 1.5 hours)
  • UAN: 0809-9999-17-648-L01-P; Knowledge (Tumor Immunology 101 (Physician/Nurse/Pharmacy Track); 1.5 hours)
  • UAN: 0809-9999-17-649-L01-P; Knowledge (Economics of Immunotherapies and Immunotherapy Combinations; 0.5 hours)
  • UAN: 0809-9999-17-650-L01-P; Knowledge (Clinical Management (Physician/Nurse/Pharmacy Track); 2.0 hours)
  • UAN: 0809-9999-17-651-L01-P; Knowledge (Emerging Models & Imaging; 1.5 hours)
  • UAN: 0809-9999-17-652-L01-P; Knowledge (Genetically Modified Cell Therapy; 2.25 hours)
  • UAN: 0809-9999-17-739-L01-P; Knowledge (Hot Topic Symposium; 2.5 hours)

Workshop:
Postgraduate Institute for Medicine designates this continuing education activity for 7.4 contact hour(s) (0.74 CEUs) of the Accreditation Council for Pharmacy Education.

  • UAN: 0809-9999-17-657-L01-P; Knowledge (Session I: Tumor Heterogeneity and Evolution under Immune Pressure and Treatment; 1.25 hours)
  • UAN: 0809-9999-17-658-L01-P; Knowledge (Session II: Tumor Immune Microenvironment; 2.5 hours)
  • UAN: 0809-9999-17-659-L01-P; Knowledge (Session III: Predictor Response & Liquid Biopsy; 1.75 hours)
  • UAN: 0809-9999-17-660-L01-P; Knowledge (Session IV: How to Apply Single Cell to Your Research; 2.0 hours)

Primer: Postgraduate Institute for Medicine designates this continuing education activity for 7.75 contact hour(s) (0.775 CEUs) of the Accreditation Council for Pharmacy Education.

  • UAN: 0809-9999-17-653-L01-P; Knowledge (Session I: Basic Immunology - A Brief Overview; 2.25 hours)
  • UAN: 0809-9999-17-654-L01-P; Knowledge (Session II: Treating Tumors with Passive Immunotherapy; 2.0 hours)
  • UAN: 0809-9999-17-655-L01-P; Knowledge (Session III: Active Immunotherapy: Unleashing the Patient's Own Immune System; 1.5 hours)
  • UAN: 0809-9999-17-656-L01-P; Knowledge (Session IV: Immune Monitoring: Figuring out How it All Works; 2.0 hours)

Pharmacists have up to 30 days to complete the evaluation and claim credit for participation so that information can be submitted to the CPE Monitor as required.  Upon receipt of the completed activity evaluation form, you will receive an email from CEcertificate@pimed.com within 3 weeks with a link and directions to submit your credit to the NABP CPE Monitor Service.

Nursing Continuing Education

Accreditation Statement

Postgraduate Institute of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit Designation

These activities are eligible for ANCC credit. Annual Meeting, Workshop, and Primer, for 20.5 contact hours, 7.3 contact hours, and 7.4 contact hours, respectively, are provided by Postgraduate Institute for Medicine.

Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.

Disclosure of Conflicts of Interest

The Postgraduate Institute for Medicine and the Society for Immunotherapy of Cancer (SITC) require instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to the Postgraduate Institute for Medicine policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.